Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From the EMPEROR-Reduced TrialCirculation 2020 Oct 23;[EPub Ahead of Print], F Zannad, JP Ferreira, SJ Pocock, C Zeller, SD Anker, J Butler, G Filippatos, SJ Hauske, M Brueckmann, E Pfarr, J Schnee, C Wanner, M Packer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.